You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: December 22, 2024

Details for Patent: 10,590,102


✉ Email this page to a colleague

« Back to Dashboard


Which drugs does patent 10,590,102 protect, and when does it expire?

Patent 10,590,102 protects COTELLIC and is included in one NDA.

Protection for COTELLIC has been extended six months for pediatric studies, as indicated by the *PED designation in the table below.

This patent has thirty-six patent family members in twenty-four countries.

Summary for Patent: 10,590,102
Title:Crystalline fumarate salt of (S)-[3,4-difluoro-2-(2-fluoro-4-iodophenylamino)phenyl] [3-hydroxy-3-(piperidin-2-yl) azetidin-1-yl]methanone
Abstract: This disclosure relates to the crystalline fumarate salt of (S)-[3,4-difluoro-2-(2-fluoro-4-iodophenylamino)phenyl] [3-hydroxy-3-(piperidin-2-yl) azetidin-1-yl]-methanone. The disclosure also relates to pharmaceutical compositions comprising the crystalline fumarate salt of (S)-[3,4-difluoro-2-(2-fluoro-4-iodophenylamino)phenyl] [3-hydroxy-3-(piperidin-2-yl) azetidin-1-yl]-methanone. The disclosure also relates to methods of treating cancers comprising administering to a patient in need thereof the crystalline fumarate salt of (S)-[3,4-difluoro-2-(2-fluoro-4-iodophenylamino)phenyl] [3-hydroxy-3-(piperidin-2-yl) azetidin-1-yl]-methanone.
Inventor(s): Brown; Adrian St. Clair (Ely, GB)
Assignee: EXELIXIS, INC. (Alameda, CA)
Application Number:15/852,280
Patent Claim Types:
see list of patent claims
Use; Composition; Compound; Process;
Patent landscape, scope, and claims:

Understanding the Scope and Claims of United States Patent 10,590,102

To delve into the specifics of the United States Patent 10,590,102, it is crucial to analyze several key aspects, including the patent's claims, the subject matter eligibility, and the broader patent landscape. Here is a detailed breakdown of these elements.

Patent Overview

United States Patent 10,590,102, like any other patent, is a grant of a property right to the inventor(s) issued by the United States Patent and Trademark Office (USPTO). This patent is part of the larger intellectual property ecosystem and is subject to the rules and guidelines set forth by the USPTO.

Claims Analysis

Claim Structure

The claims of a patent are the most critical part as they define the scope of the invention. Claims can be independent or dependent, with independent claims standing alone and dependent claims referring back to another claim[3].

Subject Matter Eligibility

The 2024 USPTO guidance update on AI patent eligibility is particularly relevant here. It emphasizes that claims must integrate judicial exceptions into practical applications to be patent-eligible. For example, if a claim involves abstract ideas or mathematical models, it must include additional elements that impose meaningful limits and transform the claim into patent-eligible subject matter[1].

Examples from the Guidance

To illustrate, consider a claim that involves data processing. If the claim merely uses a mathematical model to manipulate data without any practical application, it would likely be rejected. However, if the claim specifies the use of the data in a real-time speech recognition system to enhance voice command accuracy, it would be considered patent-eligible due to its practical application and tangible benefits[1].

Patent Claims and Scope

Claim Types

  • Independent Claims: These define the invention broadly and are not dependent on other claims.
  • Dependent Claims: These narrow down the invention and refer back to an independent claim.

Scope of Protection

The scope of protection is determined by the claims, and it is essential to ensure that the claims are clear, concise, and cover the full range of the invention without being overly broad or vague.

Inventorship and Ownership

Determining the true and only inventors is crucial for US patent applications. Inventorship involves the conception of the idea and the reduction of the idea to practice. The Court of Appeals for the Federal Circuit has emphasized the importance of correctly identifying inventors to avoid legal issues[5].

Patent Landscape

Related Patents and Prior Art

Understanding the patent landscape involves identifying related patents and prior art. This helps in assessing the novelty and non-obviousness of the invention. The USPTO's Patent Claims Research Dataset can be a valuable resource for analyzing trends and scope measurements of patents[3].

Expiration Dates and Patent Term Adjustments

Patent expiration dates and any patent term adjustments (PTA) or patent term extensions (PTE) are critical for understanding the patent's lifespan. For instance, the Allergan case highlights the complexities of patent term adjustments and double patenting issues, which can affect the validity and expiration of patents[2].

Case Law and Judicial Precedents

Judicial precedents play a significant role in shaping patent law. Cases such as Allergan USA, Inc. v. MSN Laboratories Private Ltd. provide insights into issues like obviousness-type double patenting and the importance of patent term adjustments[2].

Practical Applications and Real-World Impact

Demonstrating the practical applications of the claimed method or system is vital for patent eligibility. For example, if a claim specifies the use of AI in a real-time speech recognition system, it must show how this application provides concrete benefits or solves specific problems in the relevant field[1].

Key Takeaways

  • Claims Must Integrate Judicial Exceptions: Claims must integrate abstract ideas or judicial exceptions into practical applications to be patent-eligible.
  • Practical Applications are Crucial: Demonstrating real-world applications and tangible benefits is essential for patent eligibility.
  • Inventorship Must be Accurately Determined: Correctly identifying the true and only inventors is vital for the validity of the patent.
  • Understanding the Patent Landscape: Analyzing related patents and prior art helps in assessing the novelty and non-obviousness of the invention.
  • Compliance with USPTO Guidelines: Adhering to the latest USPTO guidance, such as the 2024 update on AI patent eligibility, is crucial for navigating the patent process successfully.

FAQs

What is the significance of the 2024 USPTO guidance update on AI patent eligibility?

The update refines and clarifies the process for determining the patent eligibility of AI-related inventions, emphasizing the integration of judicial exceptions into practical applications.

How do practical applications impact patent eligibility?

Practical applications transform abstract ideas into patent-eligible subject matter by providing concrete benefits or solving specific problems in the relevant field.

Why is accurate inventorship important in US patent applications?

Accurate inventorship is crucial because it ensures that the true and only inventors are listed, which is a requirement for patent validity and can avoid legal disputes.

What is the role of the Patent Claims Research Dataset in patent analysis?

The dataset provides detailed information on claims from US patents and applications, helping in analyzing trends and scope measurements of patents.

How do patent term adjustments and extensions affect patent validity?

Patent term adjustments and extensions can impact the expiration dates of patents and affect their validity, particularly in cases involving double patenting issues.

Cited Sources

  1. Understanding the 2024 USPTO Guidance Update on AI Patent - Mintz.
  2. ALLERGAN USA, INC. v. MSN LABORATORIES PRIVATE LTD. - CAFC.
  3. Patent Claims Research Dataset - USPTO.
  4. Crystals of (S)-[3,4-difluoro-2-(2-fluoro-4 ... - PubChem.
  5. Determining Inventorship for US Patent Applications - Oregon State University.

More… ↓

⤷  Subscribe


Drugs Protected by US Patent 10,590,102

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Patented / Exclusive Use Submissiondate
Genentech Inc COTELLIC cobimetinib fumarate TABLET;ORAL 206192-001 Nov 10, 2015 RX Yes Yes ⤷  Subscribe ⤷  Subscribe Y ⤷  Subscribe
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Patented / Exclusive Use >Submissiondate

International Family Members for US Patent 10,590,102

Country Patent Number Estimated Expiration Supplementary Protection Certificate SPC Country SPC Expiration
Argentina 105483 ⤷  Subscribe
Australia 2016288209 ⤷  Subscribe
Australia 2021200202 ⤷  Subscribe
Brazil 112017028516 ⤷  Subscribe
Canada 2990222 ⤷  Subscribe
>Country >Patent Number >Estimated Expiration >Supplementary Protection Certificate >SPC Country >SPC Expiration

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.